Medtronic announced that the US Food and Drug Administration (FDA) has cleared its Hugo Robotic-Assisted Surgery (RAS) system for use in general surgery procedures, expanding its application beyond urology in the US.
The clearance covers upper abdominal procedures, including cholecystectomy, Roux-en-Y gastric bypass, ventral hernia and small bowel resection, as well as lower abdominal procedures such as inguinal hernia repair and appendectomy. These procedures account for approximately 3.5 million surgeries annually in the US.
The Hugo RAS system features a modular design that allows surgical teams to configure robotic arms according to the procedure, surgical technique and patient's anatomy. Its open console also enables communication between the surgeon and the operating room team.
The system supports Medtronic's LigaSure RAS Maryland instrument, which incorporates vessel-sealing technology previously used in more than 45 million open and laparoscopic procedures.
According to Medtronic, the Hugo RAS system is being used across a growing number of hospitals and health systems in the US. Globally, procedure volumes have grown at more than twice the rate of the robotic surgery market, with the company expecting the system to surpass 50,000 procedures by the end of its fiscal year.
The latest FDA clearance expands the system's application in the US and provides hospitals with additional robotic-assisted options for general surgery procedures. Medtronic has been supplying surgical technologies for open and laparoscopic procedures for more than five decades.
Last news about this category
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy